These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32673367)

  • 1. Seroprevalence of neutralizing antibodies against human adenovirus type 55 in the South Korean military, 2018-2019.
    Park SY; Ko JH; Monoldorova S; Jeong J; Jeon BY; Kwon SH
    PLoS One; 2020; 15(7):e0236040. PubMed ID: 32673367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018.
    Ko JH; Woo HT; Oh HS; Moon SM; Choi JY; Lim JU; Kim D; Byun J; Kwon SH; Kang D; Heo JY; Peck KR
    Korean J Intern Med; 2021 Jan; 36(1):205-213. PubMed ID: 31480827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
    Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
    Front Immunol; 2018; 9():335. PubMed ID: 29563911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
    Wang X; Kerkmann L; Hetzel M; Windmann S; Trilling M; Zhang W; Ehrhardt A; Bayer W
    J Virol; 2022 Nov; 96(22):e0113322. PubMed ID: 36342295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing epitopes mapping of human adenovirus type 14 hexon.
    Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
    Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
    Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular Disorders.
    Klann PJ; Wang X; Elfert A; Zhang W; Köhler C; Güttsches AK; Jacobsen F; Weyen U; Roos A; Ehrke-Schulz E; Ehrhardt A; Vorgerd M; Bayer W
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China.
    Tian X; Fan Y; Wang C; Liu Z; Liu W; Xu Y; Mo C; You A; Li X; Rong X; Zhou R
    Virol Sin; 2021 Jun; 36(3):373-381. PubMed ID: 33165772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.
    Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L
    Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
    Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
    Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines.
    Francisco AG; Reyes JCB; Tabios IKB; Cruz CJG; Ang MAC; Heralde FM; Lacuna ARG; de Paz-Silava SLM
    PLoS One; 2023; 18(12):e0293046. PubMed ID: 38039314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3.
    Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R
    Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
    Li Q; Liu Q; Huang W; Song A; Zhao C; Wu J; Wang Y
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile Respiratory Illness Associated with Human Adenovirus Type 55 in South Korea Military, 2014-2016.
    Yoo H; Gu SH; Jung J; Song DH; Yoon C; Hong DJ; Lee EY; Seog W; Hwang IU; Lee D; Jeong ST; Huh K
    Emerg Infect Dis; 2017 Jun; 23(6):1016-1020. PubMed ID: 28518038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
    Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
    Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Epidemiology of Human Adenovirus-Associated Febrile Respiratory Illness in Soldiers, South Korea
    Heo JY; Noh JY; Jeong HW; Choe KW; Song JY; Kim WJ; Cheong HJ
    Emerg Infect Dis; 2018 Jul; 24(7):1221-1227. PubMed ID: 29912713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7.
    Wang R; Lu J; Zhou Q; Chen L; Huang Y; Yu Y; Yang Z
    Front Cell Infect Microbiol; 2019; 9():417. PubMed ID: 31867291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China.
    Sun C; Zhang Y; Feng L; Pan W; Zhang M; Hong Z; Ma X; Chen X; Chen L
    Vaccine; 2011 May; 29(22):3837-41. PubMed ID: 21447314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
    Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
    Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.